423 filings
Page 3 of 22
8-K
myikk
10 Jul 23
Regulation FD Disclosure
4:06pm
424B5
kmheu9q
2 Jun 23
Prospectus supplement for primary offering
5:08pm
8-K
bgbveuvpg1x1e44
26 May 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
w3tpe33hq33pr7x
9 May 23
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
vlao6lar3h0apahgzhuq
3 May 23
Soleno Therapeutics Completes Enrollment in Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
5:26pm
ARS
wtas7
20 Apr 23
Annual report to shareholders
4:05pm
S-8
jtf0udrmwa
23 Mar 23
Registration of securities for employees
4:06pm
8-K
xmnutp3rvg
21 Mar 23
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
4:05pm
8-K
wjve5w538luf
24 Feb 23
Departure of Directors or Certain Officers
4:06pm
8-K
mijnqkhidzmz kp
30 Jan 23
Departure of Directors or Certain Officers
6:05am
8-K
m44j8 lqnug
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
qdyz wpul5x
9 Nov 22
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:11pm
8-K
2bl9ncwbt0d2uomnv
3 Oct 22
Soleno Therapeutics Announces Initiation of Randomized Withdrawal Study of
9:00am
8-K
5e34yzgw 0m
25 Aug 22
Amendments to Articles of Incorporation or Bylaws
6:01am